搜索医生

Farwa Ali, M.B.B.S.

  1. Neurologist
预约门诊

出版物

  1. Alexandres CA, McCarter SJ, Tabatabai GM, LeClair-Visonneau L, Feemster JC, Gossard TR, Strainis EP, Jagielski JT, Kelleher MR, Finstuen T, Ali F, Botha H, Graff-Radford J, Olson EJ, Sandness DJ, Morgenthaler TJ, Kantarci K, Savica R, Singer W, Covassin N, Somers VK, Kirkland JL, Junna M, Lipford M, Matarese CA, Moore JL, Tippmann-Peikert M, Carvalho DZ, Boeve BF, Silber MH, St Louis EK. Phenoconversion in Women and Men With Isolated REM Sleep Behavior Disorder: A Retrospective Cohort Study. Neurology. 2024 Nov 26; 103 (10):e209993 Epub 2024 Oct 25
    View PubMed
  2. Sekiya H, Satoh R, Ali F, Dickson DW, Whitwell JL, Josephs KA. Utilizing quantitative susceptibility mapping to differentiate primary lateral sclerosis from progressive supranuclear palsy: A case report. Neuropathology. 2024 Nov 18 [Epub ahead of print]
    View PubMed
  3. Krell-Roesch J, Syrjanen JA, Moeller T, Krafft J, Barisch-Fritz B, Kremers WK, Ali F, Knopman DS, Petersen RC, Stein T, Woll A, Vassilaki M, Geda YE. Self-reported physical activity and gait in older adults without dementia: A longitudinal study. Health Sci Rep. 2024 Nov; 7 (11):e70108 Epub 2024 Nov 06
    View PubMed
  4. Badihian N, Tosakulwong N, Weigand SD, Ali F, Clark HM, Stierwalt J, Botha H, Savica R, Dickson DW, Whitwell JL, Josephs KA. Relationships between regional burden of tau pathology and age at death and disease duration in PSP. Parkinsonism Relat Disord. 2024 Oct; 127:107109 Epub 2024 Aug 17
    View PubMed
  5. Banks SA, Ali F, Klassen BT, Clarke MJ, Tobin WO. Polyminimyoclonus in Hirayama Disease. Neurology. 2024 Aug 27; 103 (4):e209740 Epub 2024 July 25
    View PubMed
  6. Amrami A, Singh NA, Ali F, Pham NTT, Stephens YC, Josephs KA, Whitwell JL. Clinical Utility of Tectal Plate Measurements on Magnetic Resonance Imaging in Progressive Supranuclear Palsy. Mov Disord. 2024 Aug; 39 (8):1402-1407 Epub 2024 Apr 08
    View PubMed
  7. Badihian N, Gatto RG, Satoh R, Ali F, Clark HM, Pham NTT, Whitwell JL, Josephs KA. Clinical and neuroimaging characteristics of primary lateral sclerosis with overlapping features of progressive supranuclear palsy. Eur J Neurol. 2024 Aug; 31 (8):e16320 Epub 2024 Apr 30
    View PubMed
  8. Garcia-Guaqueta DP, Stephens YC, Ali F, Utianski RL, Duffy JR, Clark HM, Thu Pham NT, Machulda MM, Lowe VJ, Dickson DW, Whitwell JL, Josephs KA. Comparing classic-onset corticobasal syndrome to speech/language-onset corticobasal syndrome. Parkinsonism Relat Disord. 2024 Aug; 125:107025 Epub 2024 June 03
    View PubMed
  9. Mazurek KA, Barnard L, Botha H, Christianson T, Graff-Radford J, Petersen R, Vemuri P, Windham BG, Jones DT, Ali F. A validation study demonstrating portable motion capture cameras accurately characterize gait metrics when compared to a pressure-sensitive walkway. Sci Rep. 2024 Jul 29; 14 (1):17464 Epub 2024 July 29
    View PubMed
  10. Black JA, Pham NTT, Ali F, Machulda MM, Lowe VJ, Josephs KA, Whitwell JL. Frontal hypometabolism in the diagnosis of progressive supranuclear palsy clinical variants. J Neurol. 2024 Jul; 271 (7):4267-4280 Epub 2024 Apr 17
    View PubMed
  11. Sohutskay DO, Suen RM, Ali F, Rosenman DJ. Dopamine Dysregulation Syndrome Presenting as Overuse of Mucuna pruriens Levodopa Supplement. J Mov Disord. 2024 Jul; 17 (3):357-359 Epub 2024 May 21
    View PubMed
  12. Ali F, Hogen CA, Miller EJ, Kaufman KR. Validation of Pelvis and Trunk Range of Motion as Assessed Using Inertial Measurement Units. Bioengineering (Basel). 2024 Jun 28; 11 (7) Epub 2024 June 28
    View PubMed
  13. Petroi-Bock D, Clark HM, Stierwalt JAG, Botha H, Ali F, Whitwell JL, Josephs KA. Influences of motor speech impairments on the presentation of dysphagia in progressive supranuclear palsy. Int J Speech Lang Pathol. 2024 Apr; 26 (2):278-288 Epub 2023 June 19
    View PubMed
  14. Badihian N, Ali F, Botha H, Savica R, Machulda MM, Clark HM, Stierwalt JAG, Pham NTT, Baker MC, Rademakers R, Lowe V, Whitwell JL, Josephs KA. The MAPT p.E342K and p.R406W mutations are associated with progressive supranuclear palsy with atypical features. Parkinsonism Relat Disord. 2024 Feb; 119:105962 Epub 2023 Dec 17
    View PubMed
  15. Satoh R, Ali F, Botha H, Lowe VJ, Josephs KA, Whitwell JL. Direct comparison between (18)F-Flortaucipir tau PET and quantitative susceptibility mapping in progressive supranuclear palsy. Neuroimage. 2024 Feb 1; 286:120509 Epub 2024 Jan 04
    View PubMed
  16. Orlandi F, Carlos AF, Ali F, Clark HM, Duffy JR, Utianski RL, Botha H, Machulda MM, Stephens YC, Schwarz CG, Senjem ML, Jack CR, Agosta F, Filippi M, Dickson DW, Josephs KA, Whitwell JL. Histologic tau lesions and magnetic resonance imaging biomarkers differ across two progressive supranuclear palsy variants. Brain Commun. 2024; 6 (2):fcae113 Epub 2024 Apr 05
    View PubMed
  17. Ali F, Clark H, Machulda M, Senjem ML, Lowe VJ, Jack CR Jr, Josephs KA, Whitwell J, Botha H. Patterns of brain volume and metabolism predict clinical features in the progressive supranuclear palsy spectrum. Brain Commun. 2024; 6 (4):fcae233 Epub 2024 July 16
    View PubMed
  18. Satoh R, Weigand SD, Pham NTT, Ali F, Arani A, Senjem ML, Jack CR Jr, Whitwell JL, Josephs KA. Magnetic Susceptibility in Progressive Supranuclear Palsy Variants, Parkinson's Disease, and Corticobasal Syndrome. Mov Disord. 2023 Dec; 38 (12):2282-2290 Epub 2023 Sept 29
    View PubMed
  19. Dale ML, Ali F, Anderson S, Bruno M, Comeau M, Diaz K, Golbe LI, Honig LS, Schmidt M, Spears C, Shurer J. Patients with progressive supranuclear palsy need to be seen sooner and more frequently. Parkinsonism Relat Disord. 2023 Nov; 116:105883 Epub 2023 Oct 04
    View PubMed
  20. Utianski RL, Martin PR, Duffy JR, Clark HM, Stierwalt JAG, Botha H, Ali F, Whitwell JL, Josephs KA. Assessing Patients and Care Partner Ratings of Communication-Related Participation Restrictions: Insights From Degenerative Disease. Am J Speech Lang Pathol. 2023 Aug 17; 32 (4S):1793-1805 Epub 2023 Feb 09
    View PubMed
  21. Utianski RL, Duffy JR, Martin PR, Clark HM, Stierwalt JAG, Botha H, Ali F, Whitwell JL, Josephs KA. Rate Modulation Abilities in Acquired Motor Speech Disorders. J Speech Lang Hear Res. 2023 Aug 17; 66 (8S):3194-3205 Epub 2023 Feb 13
    View PubMed
  22. Shir D, Pham NTT, Botha H, Koga S, Kouri N, Ali F, Knopman DS, Petersen RC, Boeve BF, Kremers WK, Nguyen AT, Murray ME, Reichard RR, Dickson DW, Graff-Radford N, Josephs KA, Whitwell J, Graff-Radford J. Clinicoradiologic and Neuropathologic Evaluation of Corticobasal Syndrome. Neurology. 2023 Jul 18; 101 (3):e289-e299 Epub 2023 June 02
    View PubMed
  23. Tisavipat N, Chang BK, Ali F, Pittock SJ, Kammeyer R, Declusin A, Cohn SJ, Flanagan EP. Subacute Horizontal Diplopia, Jaw Dystonia, and Laryngospasm. Neurol Neuroimmunol Neuroinflamm. 2023 Jul; 10 (4) Epub 2023 June 13
    View PubMed
  24. Jusue-Torres I, Brown DA, Pennington Z, Cogswell PM, Ali F, Graff-Radford N, Jones DT, Cutsforth-Gregory JK, Graff-Radford J, Kaufman KR, Elder BD. Objective assessment of patients with idiopathic normal pressure hydrocephalus following ventriculoperitoneal shunt placement using activity-monitoring data: pilot study. Neurosurg Focus. 2023 Apr; 54 (4):E6
    View PubMed
  25. Pavone C, Weigand SW, Ali F, Clark HM, Botha H, Machulda MM, Savica R, Pham NTT, Grijalva RM, Schwarz CG, Senjem ML, Agosta F, Filippi M, Jack CR, Lowe VJ, Josephs KA, Whitwell JL. Longitudinal clinical decline and baseline predictors in progressive supranuclear palsy. Parkinsonism Relat Disord. 2023 Feb; 107:105290 Epub 2023 Jan 16
    View PubMed
  26. Buciuc M, Koga S, Pham NTT, Duffy JR, Knopman DS, Ali F, Boeve BF, Graff-Radford J, Botha H, Lowe VJ, Nguyen A, Reichard RR, Dickson DW, Petersen RC, Whitwell JL, Josephs KA. The many faces of globular glial tauopathy: A clinical and imaging study. Eur J Neurol. 2023 Feb; 30(2):321-333. Epub 2022 Nov 01.
    View PubMed
  27. Utianski RL, Trang Thu Pham N, Botha H, Ali F, Duffy JR, Clark HM, Lowe VJ, Whitwell JL, Josephs KA. Longitudinal changes in dopamine transporter uptake scans in progressive apraxia of speech. Clin Park Relat Disord. 2023; 9:100207 Epub 2023 June 16
    View PubMed
  28. Utianski RL, Clark HM, Martin PR, Stierwalt JAG, Duffy JR, Botha H, Ali F, Josephs KA. Patient and Care Partner Ratings of Communication Participation in Frontotemporal Dementia. Alzheimers Dement. 2022 Dec; 18 Suppl 9:e060715
    View PubMed
  29. Josephs KA, Tosakulwong N, Gatto RG, Weigand SD, Ali F, Botha H, Graff-Radford J, Machulda MM, Savica R, Schwarz CG, Senjem ML, Boeve BF, Kantarci K, Jones DT, Ramanan VK, Fields JA, Reichard RR, Dickson DW, Petersen RC, Jack CR Jr, Lowe VJ, Whitwell JL. Optimum Differentiation of Frontotemporal Lobar Degeneration from Alzheimer Disease Achieved with Cross-Sectional Tau Positron Emission Tomography. Ann Neurol. 2022 Dec; 92 (6):1016-1029 Epub 2022 Aug 29
    View PubMed
  30. Carlos AF, Sekiya H, Koga S, Pham NTT, Ali F, Botha H, Clark HM, Coon EA, Lowe V, Ahlskog JE, Trejo-Lopez JA, Dickson DW, Whitwell JL, Josephs KA. Tau-PET and multimodal imaging in clinically atypical multiple system atrophy masquerading as progressive supranuclear palsy. Parkinsonism Relat Disord. 2022 Aug; 101:9-14 Epub 2022 June 16
    View PubMed
  31. Grijalva RM, Pham NTT, Huang Q, Martin PR, Ali F, Clark HM, Duffy JR, Utianski RL, Botha H, Machulda MM, Weigand SD, Ahlskog JE, Dickson DW, Josephs KA, Whitwell JL. Brainstem Biomarkers of Clinical Variant and Pathology in Progressive Supranuclear Palsy. Mov Disord. 2022 Apr; 37 (4):702-712 Epub 2021 Dec 31
    View PubMed
  32. Ali F, Benarroch E. What Is the Brainstem Control of Locomotion? Neurology. 2022 Mar 15; 98 (11):446-451
    View PubMed
  33. Bower SM, Weigand SD, Ali F, Clark HM, Botha H, Stierwalt JA, Whitwell JL, Josephs KA. Depression and Apathy across Different Variants of Progressive Supranuclear Palsy. Mov Disord Clin Pract. 2022 Feb; 9 (2):212-217 Epub 2021 Dec 31
    View PubMed
  34. Chou CZ, Ahlskog JE, Klassen BT, Coon EA, Ali F, Bower JH, Savica R, Hassan A. Utility of routine surface electrophysiology to screen for functional tremor prior to surgical treatment of essential tremor. Clin Park Relat Disord. 2022; 7:100149 Epub 2022 June 16
    View PubMed
  35. Gatto RG, Martin PR, Ali F, Clark HM, Duffy JR, Utianski RL, Botha H, Machulda MM, Dickson DW, Josephs KA, Whitwell JL. Diffusion tractography of superior cerebellar peduncle and dentatorubrothalamic tracts in two autopsy confirmed progressive supranuclear palsy variants: Richardson syndrome and the speech-language variant. Neuroimage Clin. 2022; 35:103030 Epub 2022 May 11
    View PubMed
  36. Carlos AF, Tosakulwong N, Weigand SD, Buciuc M, Ali F, Clark HM, Botha H, Utianski RL, Machulda MM, Schwarz CG, Reid RI, Senjem ML, Jack CR Jr, Ahlskog JE, Dickson DW, Josephs KA, Whitwell JL. Histologic lesion type correlates of magnetic resonance imaging biomarkers in four-repeat tauopathies. Brain Commun. 2022; 4 (3):fcac108 Epub 2022 Apr 28
    View PubMed
  37. Hokelekli FO, Duffy JR, Clark HM, Utianski RL, Botha H, Ali F, Stierwalt JA, Machulda MM, Reichard RR, Dickson DW, Whitwell JL, Josephs KA. Autopsy Validation of Progressive Supranuclear Palsy-Predominant Speech/Language Disorder Criteria. Mov Disord. 2022 Jan; 37 (1):213-218 Epub 2021 Oct 10
    View PubMed
  38. Lucien F, Benarroch EE, Mullan A, Ali F, Boeve BF, Mielke MM, Petersen RC, Kim Y, Stang C, Camerucci E, Ross OA, Wszolek ZK, Knopman D, Bower J, Singer W, Savica R. Poly (ADP-Ribose) and alpha-synuclein extracellular vesicles in patients with Parkinson disease: A possible biomarker of disease severity. PLoS One. 2022; 17 (4):e0264446 Epub 2022 Apr 08
    View PubMed
  39. Clark HM, Tosakulwong N, Weigand SD, Ali F, Botha H, Pham NTT, Schwarz CG, Reid RI, Senjem ML, Jack CR Jr, Lowe VJ, Ahlskog JE, Josephs KA, Whitwell JL. Gray and White Matter Correlates of Dysphagia in Progressive Supranuclear Palsy. Mov Disord. 2021 Nov; 36 (11):2669-2675 Epub 2021 Aug 23
    View PubMed
  40. Ali F, Loushin SR, Botha H, Josephs KA, Whitwell JL, Kaufman K. Laboratory based assessment of gait and balance impairment in patients with progressive supranuclear palsy. J Neurol Sci. 2021 Oct 15; 429:118054 Epub 2021 Aug 25
    View PubMed
  41. Hokelekli FO, Ali F, Carlos AF, Martin PR, Clark HM, Duffy JR, Utianski RL, Botha H, St Louis EK, Whitwell JL, Josephs KA. Sleep disturbances in the speech-language variant of progressive supranuclear palsy. Parkinsonism Relat Disord. 2021 Oct; 91:9-12 Epub 2021 Aug 18
    View PubMed
  42. Whitwell JL, Tosakulwong N, Clark HM, Ali F, Botha H, Weigand SD, Sintini I, Machulda MM, Schwarz CG, Reid RI, Jack CR Jr, Ahlskog JE, Josephs KA. Diffusion tensor imaging analysis in three progressive supranuclear palsy variants. J Neurol. 2021 Sep; 268 (9):3409-3420 Epub 2021 Mar 12
    View PubMed
  43. Clark HM, Utianski RL, Ali F, Botha H, Whitwell JL, Josephs KA. Motor Speech Disorders and Communication Limitations in Progressive Supranuclear Palsy. Am J Speech Lang Pathol. 2021 Jun 18; 30 (3S):1361-1372 Epub 2021 Mar 09
    View PubMed
  44. Josephs KA, Duffy JR, Clark HM, Utianski RL, Strand EA, Machulda MM, Botha H, Martin PR, Pham NTT, Stierwalt J, Ali F, Buciuc M, Baker M, Fernandez De Castro CH, Spychalla AJ, Schwarz CG, Reid RI, Senjem ML, Jack CR Jr, Lowe VJ, Bigio EH, Reichard RR, Polley EJ, Ertekin-Taner N, Rademakers R, DeTure MA, Ross OA, Dickson DW, Whitwell JL. A molecular pathology, neurobiology, biochemical, genetic and neuroimaging study of progressive apraxia of speech. Nat Commun. 2021 Jun 8; 12 (1):3452 Epub 2021 June 08
    View PubMed
  45. Mansukhani SA, Zalewski NL, Hur M, Ali F, Olsen TW, Bhatti MT, Chen JJ. Sea Fan Frond Neovascularization: A Unique Finding in a Patient With Susac Syndrome. J Neuroophthalmol. 2021 Jun 1; 41 (2):e160-e162
    View PubMed
  46. Sintini I, Kaufman K, Botha H, Martin PR, Loushin SR, Senjem ML, Reid RI, Schwarz CG, Jack CR Jr, Lowe VJ, Josephs KA, Whitwell JL, Ali F. Neuroimaging correlates of gait abnormalities in progressive supranuclear palsy. Neuroimage Clin. 2021; 32:102850 Epub 2021 Oct 12
    View PubMed
  47. Jackson L, Klassen BT, Hassan A, Bower JH, Matsumoto JY, Coon EA, Ali F. Utility of tremor electrophysiology studies. Clin Park Relat Disord. 2021; 5:100108 Epub 2021 Sept 24
    View PubMed
  48. Bluett B, Pantelyat AY, Litvan I, Ali F, Apetauerova D, Bega D, Bloom L, Bower J, Boxer AL, Dale ML, Dhall R, Duquette A, Fernandez HH, Fleisher JE, Grossman M, Howell M, Kerwin DR, Leegwater-Kim J, Lepage C, Ljubenkov PA, Mancini M, McFarland NR, Moretti P, Myrick E, Patel P, Plummer LS, Rodriguez-Porcel F, Rojas J, Sidiropoulos C, Sklerov M, Sokol LL, Tuite PJ, VandeVrede L, Wilhelm J, Wills AA, Xie T, Golbe LI. Best Practices in the Clinical Management of Progressive Supranuclear Palsy and Corticobasal Syndrome: A Consensus Statement of the CurePSP Centers of Care. Front Neurol. 2021; 12:694872 Epub 2021 July 01
    View PubMed
  49. Seckin ZI, Duffy JR, Strand EA, Clark HM, Utianski RL, Machulda MM, Botha H, Ali F, Thu Pham NT, Lowe VJ, Whitwell JL, Josephs KA. The evolution of parkinsonism in primary progressive apraxia of speech: A 6-year longitudinal study. Parkinsonism Relat Disord. 2020 Dec; 81:34-40. Epub 2020 Oct 07.
    View PubMed
  50. Ghirelli A, Tosakulwong N, Weigand SD, Clark HM, Ali F, Botha H, Duffy JR, Utianski RL, Buciuc M, Murray ME, Labuzan SA, Spychalla AJ, Pham NTT, Schwarz CG, Senjem ML, Machulda MM, Baker M, Rademakers R, Filippi M, Jack CR Jr, Lowe VJ, Parisi JE, Dickson DW, Josephs KA, Whitwell JL. Sensitivity-Specificity of Tau and Amyloid beta Positron Emission Tomography in Frontotemporal Lobar Degeneration. Ann Neurol. 2020 Nov; 88 (5):1009-1022 Epub 2020 Sept 12
    View PubMed
  51. Seckin ZI, Whitwell JL, Utianski RL, Botha H, Ali F, Duffy JR, Clark HM, Machulda MM, Jordan LG, Min HK, Lowe VJ, Josephs KA. Ioflupane 123I (DAT scan) SPECT identifies dopamine receptor dysfunction early in the disease course in progressive apraxia of speech. J Neurol. 2020 Sep; 267(9):2603-2611. Epub 2020 May 09.
    View PubMed
  52. Clark HM, Stierwalt JAG, Tosakulwong N, Botha H, Ali F, Whitwell JL, Josephs KA. Dysphagia in Progressive Supranuclear Palsy. Dysphagia. 2020 Aug; 35 (4):667-676 Epub 2019 Nov 01
    View PubMed
  53. McCarter SJ, Stang C, Turcano P, Mielke MM, Ali F, Bower JH, Savica R. Higher vitamin B12 level at Parkinson's disease diagnosis is associated with lower risk of future dementia. Parkinsonism Relat Disord. 2020 Apr; 73:19-22 Epub 2020 Mar 16
    View PubMed
  54. Ali F, Wijdicks EF. Treatment of Movement Disorder Emergencies in Autoimmune Encephalitis in the Neurosciences ICU. Neurocrit Care. 2020 Feb; 32 (1):286-294
    View PubMed
  55. Whitwell JL, Tosakulwong N, Botha H, Ali F, Clark HM, Duffy JR, Utianski RL, Stevens CA, Weigand SD, Schwarz CG, Senjem ML, Jack CR, Lowe VJ, Ahlskog JE, Dickson DW, Josephs KA. Brain volume and flortaucipir analysis of progressive supranuclear palsy clinical variants. Neuroimage Clin. 2020; 25:102152 Epub 2019 Dec 28
    View PubMed
  56. Sintini I, Schwarz CG, Senjem ML, Reid RI, Botha H, Ali F, Ahlskog JE, Jack CR Jr, Lowe VJ, Josephs KA, Whitwell JL. Multimodal neuroimaging relationships in progressive supranuclear palsy. Parkinsonism Relat Disord. 2019 Sep; 66:56-61. Epub 2019 Jul 02.
    View PubMed
  57. Ali F, Martin PR, Botha H, Ahlskog JE, Bower JH, Masumoto JY, Maraganore D, Hassan A, Eggers S, Boeve BF, Knopman DS, Drubach D, Petersen RC, Dunkley ED, van Gerpen J, Uitti R, Whitwell JL, Dickson DW, Josephs KA. Sensitivity and Specificity of Diagnostic Criteria for Progressive Supranuclear Palsy. Mov Disord. 2019 Aug; 34 (8):1144-1153 Epub 2019 Feb 06
    View PubMed
  58. Ali F, Kumar N, Dyck PJB, Berini S, Klaas J. Porphyria: A rare differential diagnosis of polyradiculoneuropathy. J Neurol Sci. 2019 Jul 15; 402:153-155 Epub 2019 May 22
    View PubMed
  59. Ali F, Botha H, Whitwell JL, Josephs KA. Utility of the Movement Disorders Society Criteria for Progressive Supranuclear Palsy in Clinical Practice. Mov Disord Clin Pract. 2019 Jul; 6 (6):436-439 Epub 2019 July 24
    View PubMed
  60. Whitwell JL, Stevens CA, Duffy JR, Clark HM, Machulda MM, Strand EA, Martin PR, Utianski RL, Botha H, Spychalla AJ, Senjem ML, Schwarz CG, Jack CR Jr, Ali F, Hassan A, Josephs KA. An Evaluation of the Progressive Supranuclear Palsy Speech/Language Variant. Mov Disord Clin Pract. 2019 Jul; 6 (6):452-461 Epub 2019 May 29
    View PubMed
  61. Ali F, Josephs K. Rare Tauopathies. Semin Neurol. 2019 Apr; 39 (2):264-273 Epub 2019 Mar 29
    View PubMed
  62. Singh TD, Swanson A, Burrows AM, Clarke M, Shah S, Ali F, Coon EA. Teaching NeuroImages: Not a typical spinal mass. Neurology. 2018 Aug 21; 91 (8):e790-e791
    View PubMed
  63. Ali F, Josephs K. The diagnosis of progressive supranuclear palsy: current opinions and challenges. Expert Rev Neurother. 2018 Jul; 18 (7):603-616 Epub 2018 June 28
    View PubMed
  64. Ali F, Matsumoto JY, Hassan A. Camptocormia: Etiology, diagnosis, and treatment response. Neurol Clin Pract. 2018 Jun; 8 (3):240-248
    View PubMed
  65. Ali F, Whitwell JL, Martin PR, Senjem ML, Knopman DS, Jack CR, Lowe VJ, Petersen RC, Boeve BF, Josephs KA. [(18)F] AV-1451 uptake in corticobasal syndrome: the influence of beta-amyloid and clinical presentation. J Neurol. 2018 May; 265 (5):1079-1088 Epub 2018 Mar 01
    View PubMed
  66. Ali F, Josephs KA. Corticobasal degeneration: key emerging issues. J Neurol. 2018 Feb; 265 (2):439-445 Epub 2017 Oct 23
    View PubMed
  67. Ali F, Murray JA, Adams AC, Flanagan EP. Clinical Reasoning: A 54-year-old woman with dementia, myoclonus, and ataxia. Neurology. 2017 Jul 11; 89 (2):e7-e12
    View PubMed
  68. Ali F, Laughlin RS. Asymptomatic CNS demyelination related to TNF-alpha inhibitor therapy. Neurol Neuroimmunol Neuroinflamm. 2017 Jan; 4 (1):e298 Epub 2016 Oct 28
    View PubMed
  69. Ali F, Young J, Rabinstein AA, Flemming KD, Fugate JE. Routine Troponin Measurements Are Unnecessary to Exclude Asymptomatic Coronary Events in Acute Ischemic Stroke Patients. J Stroke Cerebrovasc Dis. 2016 May; 25 (5):1215-1221 Epub 2016 Feb 28
    View PubMed
  70. Siddiqui UT, Shakoor A, Kiani S, Ali F, Sharif M, Kumar A, Raza Q, Khan N, Alamzaib SM, Farid-ul-Husnain S. Attitudes of medical students towards incentives offered by pharmaceutical companies -- perspective from a developing nation -- a cross-sectional study. BMC Med Ethics. 2014 May 5; 15:36 Epub 2014 May 05
    View PubMed
  71. Abidi SH, Ali F, Shah F, Abbas F, Ali S. Burden of communicable disease among the native and repatriating Afghans. PLoS Pathog. 2012; 8 (10):e1002926 Epub 2012 Oct 25
    View PubMed
PST-20477991